These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9479358)

  • 1. [Prognostic significance of immunocompetent cell infiltration of breast tumor tissue].
    Perel'muter VM; Slonimskaia EM; Cherdyntseva NV; Afrimson EA
    Vopr Onkol; 1997; 43(6):596-8. PubMed ID: 9479358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cellular reactions in tumor stroma and reactive changes in regional lymph nodes in breast cancer].
    Fedin IuV; Ermilova VD
    Vopr Onkol; 1984; 30(11):38-44. PubMed ID: 6334934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sinus histiocytosis of the regional lymph nodes as an indicator of antitumor resistance in breast cancer].
    Loboda VI; Grinevich IuA
    Arkh Patol; 1982; 44(10):45-9. PubMed ID: 7181708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
    Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Functional activity of the regional lymph nodes in breast cancer patients].
    Loboda VI; Grinevich IuA
    Vopr Onkol; 1983; 29(2):31-6. PubMed ID: 6601329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of regulatory T cells in sentinel lymph nodes is a prognostic predictor in patients with node-negative breast cancer.
    Nakamura R; Sakakibara M; Nagashima T; Sangai T; Arai M; Fujimori T; Takano S; Shida T; Nakatani Y; Miyazaki M
    Eur J Cancer; 2009 Aug; 45(12):2123-31. PubMed ID: 19398324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer stromal myxoid changes are associated with tumor invasion and metastasis: a central role for hyaluronan.
    Wernicke M; Piñeiro LC; Caramutti D; Dorn VG; Raffo MM; Guixa HG; Telenta M; Morandi AA
    Mod Pathol; 2003 Feb; 16(2):99-107. PubMed ID: 12591961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism.
    Papadopoulou E; Anagnostopoulos K; Tripsianis G; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A
    Neoplasma; 2008; 55(3):229-38. PubMed ID: 18348656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD1a down-regulation in primary invasive ductal breast carcinoma may predict regional lymph node invasion and patient outcome.
    La Rocca G; Anzalone R; Corrao S; Magno F; Rappa F; Marasà S; Czarnecka AM; Marasà L; Sergi C; Zummo G; Cappello F
    Histopathology; 2008 Jan; 52(2):203-12. PubMed ID: 18184269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: A new independent prognostic marker in primary breast cancer.
    Scorilas A; Talieri M; Ardavanis A; Courtis N; Dimitriadis E; Yotis J; Tsiapalis CM; Trangas T
    Cancer Res; 2000 Oct; 60(19):5427-33. PubMed ID: 11034084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
    Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
    Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome.
    Camp RL; Rimm EB; Rimm DL
    Cancer; 2000 Jan; 88(1):108-13. PubMed ID: 10618612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cathepsin B in infiltrated lymph nodes is of prognostic significance for patients with nonsmall cell lung carcinoma.
    Werle B; Kraft C; Lah TT; Kos J; Schanzenbächer U; Kayser K; Ebert W; Spiess E
    Cancer; 2000 Dec; 89(11):2282-91. PubMed ID: 11147599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of intramammary lymph nodes in the staging of breast cancer: correlation with tumor characteristics and outcome.
    Nassar A; Cohen C; Cotsonis G; Carlson G
    Breast J; 2008; 14(2):147-52. PubMed ID: 18248563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between hemostatic parameters and prognostic/predictive factors in breast cancer.
    Yigit E; Gönüllü G; Yücel I; Turgut M; Erdem D; Cakar B
    Eur J Intern Med; 2008 Dec; 19(8):602-7. PubMed ID: 19046726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting distant dissemination in patients with early breast cancer.
    Arriagada R; Rutqvist LE; Johansson H; Kramar A; Rotstein S
    Acta Oncol; 2008; 47(6):1113-21. PubMed ID: 18607866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunocyte subpopulations in histologic sections of breast tumors].
    Tupitsyn NN; Artamonova EV; Kadagidze ZG; Blokhina NG; Baryshnikov AI; Moldenhauer H; Boumcelle L
    Vopr Onkol; 1994; 40(7-12):314-8. PubMed ID: 7610627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of desmoplastic reaction and lymphocytic infiltration in the management of breast cancer.
    Cardone A; Tolino A; Zarcone R; Borruto Caracciolo G; Tartaglia E
    Panminerva Med; 1997 Sep; 39(3):174-7. PubMed ID: 9360417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.